104 related articles for article (PubMed ID: 15663560)
1. The effect of specific immunotherapy on the expression of costimulatory molecules in late phase reaction of the skin in allergic patients.
Plewako H; Arvidsson M; Oancea I; Hasséus B; Dahlgren U; Rak S
Clin Exp Allergy; 2004 Dec; 34(12):1862-7. PubMed ID: 15663560
[TBL] [Abstract][Full Text] [Related]
2. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
3. A follow-up study of immunotherapy-treated birch-allergic patients: effect on the expression of chemokines in the nasal mucosa.
Plewako H; Holmberg K; Oancea I; Gotlib T; Samoliński B; Rak S
Clin Exp Allergy; 2008 Jul; 38(7):1124-31. PubMed ID: 18691293
[TBL] [Abstract][Full Text] [Related]
4. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
5. Langerhans' cells in vernal keratoconjunctivitis express the costimulatory molecule B7-2 (CD86), but not B7-1 (CD80).
Abu-El-Asrar AM; Al-Kharashi SA; Al-Mansouri S; Missotten L; Geboes K
Eye (Lond); 2001 Oct; 15(Pt 5):648-54. PubMed ID: 11702979
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
[TBL] [Abstract][Full Text] [Related]
7. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
Varney VA; Hamid QA; Gaga M; Ying S; Jacobson M; Frew AJ; Kay AB; Durham SR
J Clin Invest; 1993 Aug; 92(2):644-51. PubMed ID: 8349803
[TBL] [Abstract][Full Text] [Related]
8. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis.
Polosa R; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Crimi N
Allergy; 2004 Nov; 59(11):1224-8. PubMed ID: 15461606
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation.
Würtzen PA; Lund G; Lund K; Arvidsson M; Rak S; Ipsen H
Clin Exp Allergy; 2008 Aug; 38(8):1290-301. PubMed ID: 18510696
[TBL] [Abstract][Full Text] [Related]
11. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects.
Kopp MV; Stenglein S; Kamin W; Friedrichs F; von Berg A; Zielen S; Hamelmann E; Wahn U; Kuehr J
Pediatr Allergy Immunol; 2007 Sep; 18(6):523-7. PubMed ID: 17680911
[TBL] [Abstract][Full Text] [Related]
13. Effects of allergen-specific immunotherapy on functions of helper and regulatory T cells in patients with seasonal allergic rhinitis.
Kirmaz C; Ozenturk Kirgiz O; Bayrak P; Yilmaz O; Vatansever S; Ozbilgin K; Onur E; Celik O; Sogut A; Ay G; Yuksel H
Eur Cytokine Netw; 2011 Mar; 22(1):15-23. PubMed ID: 21421451
[TBL] [Abstract][Full Text] [Related]
14. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
[TBL] [Abstract][Full Text] [Related]
15. Aluminium hydroxide down-regulates T helper 2 responses by allergen-stimulated human peripheral blood mononuclear cells.
Wilcock LK; Francis JN; Durham SR
Clin Exp Allergy; 2004 Sep; 34(9):1373-8. PubMed ID: 15347369
[TBL] [Abstract][Full Text] [Related]
16. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
17. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of plasma and cell surface co-stimulatory molecules CTLA-4, CD28 and CD86 in adult patients with allergic asthma.
Wong CK; Lun SW; Ko FW; Ip WK; Hui DS; Lam CW
Clin Exp Immunol; 2005 Jul; 141(1):122-9. PubMed ID: 15958078
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of the costimulatory molecules CD80, CD86, CD152, PD-1 and ICOS on T-cells from paracoccidioidomycosis patients: lack of correlation with T-cell hyporesponsiveness.
Cacere CR; Mendes-Giannini MJ; Fontes CJ; Kono A; Duarte AJ; Benard G
Clin Immunol; 2008 Nov; 129(2):341-9. PubMed ID: 18757242
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]